Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Nat Biotechnol. 2009 Oct;27(10):933-40. doi: 10.1038/nbt.1566. Epub 2009 Oct 4.
Constitutive activation of one or more kinase signaling pathways is a hallmark of many cancers. Here we extend the previously described mass spectrometry-based KAYAK approach by monitoring kinase activities from multiple signaling pathways simultaneously. This improved single-reaction strategy, which quantifies the phosphorylation of 90 synthetic peptides in a single mass spectrometry run, is compatible with nanogram to microgram amounts of cell lysate. Furthermore, the approach enhances kinase monospecificity through substrate competition effects, faithfully reporting the signatures of many signaling pathways after mitogen stimulation or of basal pathway activation differences across a panel of well-studied cancer cell lines. Hierarchical clustering of activities from related experiments groups peptides phosphorylated by similar kinases together and, when combined with pathway alteration using pharmacological inhibitors, distinguishes underlying differences in potency, off-target effects and genetic backgrounds. Finally, we introduce a strategy to identify the kinase, and even associated protein complex members, responsible for phosphorylation events of interest.
组成性激活一个或多个激酶信号通路是许多癌症的标志。在这里,我们通过同时监测来自多个信号通路的激酶活性,扩展了之前描述的基于质谱的 KAYAK 方法。这种改进的单反应策略可在单次质谱运行中定量 90 种合成肽的磷酸化,适用于纳克到微克量的细胞裂解物。此外,该方法通过底物竞争效应增强激酶的单特异性,在有丝分裂原刺激后或在一组经过充分研究的癌细胞系中,忠实地报告许多信号通路的特征,或基础通路激活差异。来自相关实验的聚类分析将被相似激酶磷酸化的肽聚集在一起,当与使用药理学抑制剂改变通路结合使用时,可以区分效力、脱靶效应和遗传背景方面的潜在差异。最后,我们引入了一种策略来鉴定负责感兴趣磷酸化事件的激酶,甚至相关的蛋白复合物成员。